Close this search box.
Close this search box.

Camp Lejeune Water Settlement – DOJ and Navy Begin to Pay Damage Awards

By David B. Rheingold, Esq.

By David B. Rheingold

Recent developments as of March 27, 2024, have shed light on the progress and challenges surrounding the Camp Lejeune Justice Act. Under this act, approximately 175,000 administrative claims have been submitted to the Navy, with a focus on providing compensation for individuals affected by exposure to contaminated water at Camp Lejeune.

Only a small fraction of these claims have been addressed, and plaintiffs have been continuously disappointed with the delays and slow pace of the Department of Justice (DOJ) and the Navy.

What Conditions Has The DOJ/Navy Already Paid Settlements For?

  • Bladder cancer
  • Kidney cancer
  • Non-Hodgkin’s lymphoma
  • Kidney disease
  • Parkinson’s disease
  • Leukemia
  • Multiple myeloma

How Many Cases Have Been Settled? And How Much Were They Worth?

Settlement values have varied, ranging from $100,000 to $450,000 for the above-mentioned conditions, depending on factors such as the severity of illness and the length of the period of contamination.

The Torts Branch of the Navy and the DOJ have been settling cases separately from each other, which raises concerns. In total, rewards have been made for 8 settlements offered by the Navy and 18 by the DOJ for the 175,000 claims filed.

While strides have been made, frustrations and delays remain prevalent among victims. It is imperative to continue advocating for transparency and expediency in the settlement process to ensure that affected individuals receive the compensation they deserve.

Contact Rheingold Giuffra Ruffo Plotkin & Hellman LLP

If you or a loved one have been affected by the Camp Lejeune water contamination between August 1, 1953, and December 31, 1987, contact Rheingold Giuffra Ruffo Plotkin & Hellman LLP for a free consultation. Our attorneys specialize in navigating complex liability cases and will work tirelessly to ensure your rights are protected.

Picture of David B. Rheingold, Partner

David B. Rheingold, Partner

David specializes in an active trial practice primarily involving drug products, medical device liability and product liability cases. On both a state and national level, he has obtained substantial client settlements through arbitration, mediation and direct negotiations with some of the largest national and international drug and medical device makers. David has been involved in multiple high-profile legal cases including the $2.5 billion DePuy ASR and DePuy Pinnacle metal-on-metal hip implant settlement plan and the $1.4 billion Stryker Rejuvenate metal-on-metal hip implant settlement plan.

Related Posts